152 related articles for article (PubMed ID: 8798408)
1. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors.
Fanjul AN; Delia D; Pierotti MA; Rideout D; Yu JQ; Pfahl M
J Biol Chem; 1996 Sep; 271(37):22441-6. PubMed ID: 8798408
[TBL] [Abstract][Full Text] [Related]
2. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide.
Sabichi AL; Hendricks DT; Bober MA; Birrer MJ
J Natl Cancer Inst; 1998 Apr; 90(8):597-605. PubMed ID: 9554442
[TBL] [Abstract][Full Text] [Related]
4. Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells.
Pergolizzi R; Appierto V; Crosti M; Cavadini E; Cleris L; Guffanti A; Formelli F
Int J Cancer; 1999 May; 81(5):829-34. PubMed ID: 10328240
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression.
Liu G; Wu M; Levi G; Ferrari N
Int J Cancer; 1998 Oct; 78(2):248-54. PubMed ID: 9754659
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
7. N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.
Sani BP; Shealy YF; Hill DL
Carcinogenesis; 1995 Oct; 16(10):2531-4. PubMed ID: 7586162
[TBL] [Abstract][Full Text] [Related]
8. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
[TBL] [Abstract][Full Text] [Related]
9. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.
Clifford JL; Menter DG; Wang M; Lotan R; Lippman SM
Cancer Res; 1999 Jan; 59(1):14-8. PubMed ID: 9892176
[TBL] [Abstract][Full Text] [Related]
10. N-(4-hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153.
Samuel W; Kutty RK; Nagineni S; Vijayasarathy C; Chandraratna RA; Wiggert B
J Cell Physiol; 2006 Dec; 209(3):854-65. PubMed ID: 16972258
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR).
Xia Y; Wong NS; Fong WF; Tideman H
Int J Cancer; 2002 Nov; 102(1):7-14. PubMed ID: 12353227
[TBL] [Abstract][Full Text] [Related]
12. Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells.
Kadara H; Lacroix L; Lotan D; Lotan R
Cancer Biol Ther; 2007 May; 6(5):705-11. PubMed ID: 17404501
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells.
Sun SY; Yue P; Lotan R
Mol Pharmacol; 1999 Mar; 55(3):403-10. PubMed ID: 10051523
[TBL] [Abstract][Full Text] [Related]
14. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
16. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk
J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422
[TBL] [Abstract][Full Text] [Related]
18. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
[TBL] [Abstract][Full Text] [Related]
19. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of nuclear retinoid receptors in normal and malignant prostates.
Lotan Y; Xu XC; Shalev M; Lotan R; Williams R; Wheeler TM; Thompson TC; Kadmon D
J Clin Oncol; 2000 Jan; 18(1):116-21. PubMed ID: 10623701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
